Monopar Therapeutics Inc
NASDAQ:MNPR
Monopar Therapeutics Inc
NASDAQ:MNPR
Price:
56.08
USD
-3.18%
Market Closed
Market Cap:
$374.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
INOX Leisure Ltd
NSE:INOXLEISUR
|
IN |
|
A
|
Arizona Sonoran Copper Company Inc
TSX:ASCU
|
CA |
|
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
|
CN |
|
Grupo Pochteca SAB de CV
BMV:POCHTECB
|
MX |
|
A
|
Arem Pacific Corp
OTC:ARPC
|
AU |
|
Aroa Biosurgery Ltd
ASX:ARX
|
NZ |
|
G
|
Garda Diversified Property Fund
ASX:GDF
|
AU |
|
Benchmark Electronics Inc
NYSE:BHE
|
US |
|
A
|
Anhui Wanwei Updated High-tech Material Industry Co Ltd
SSE:600063
|
CN |
|
W
|
Waterdrop Inc
NYSE:WDH
|
CN |
|
Atlantic American Corp
NASDAQ:AAME
|
US |
|
T
|
TeamViewer SE
F:TMV1
|
DE |
|
E
|
E-Data Teknoloji Pazarlama AS
IST:EDATA.E
|
TR |
|
Eolus Vind AB (publ)
STO:EOLU B
|
SE |
|
S
|
SRIVARU Holding Ltd
NASDAQ:SVMH
|
KY |
|
TCI Express Ltd
NSE:TCIEXP
|
IN |
|
TTK Prestige Ltd
NSE:TTKPRESTIG
|
IN |
|
Lazydays Holdings Inc
F:5ZL
|
US |
Income Statement
Earnings Waterfall
Monopar Therapeutics Inc
Monopar Therapeutics Inc
Income Statement
Monopar Therapeutics Inc
Monopar Therapeutics Inc
Currency: USD
| Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||
| Operating Expenses |
(17)
|
(17)
|
(17)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(10)
|
(10)
|
(9)
|
(8)
|
(7)
|
(7)
|
(16)
|
(18)
|
(19)
|
(22)
|
(17)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
|
| Research & Development |
(15)
|
(16)
|
(16)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(7)
|
(8)
|
(8)
|
(7)
|
(7)
|
(6)
|
(5)
|
(4)
|
(4)
|
(13)
|
(14)
|
(14)
|
(16)
|
(10)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(17)
N/A
|
(17)
-3%
|
(17)
-1%
|
(3)
+82%
|
(3)
-6%
|
(4)
-16%
|
(4)
-2%
|
(4)
-2%
|
(4)
-7%
|
(4)
+6%
|
(5)
-13%
|
(5)
-19%
|
(7)
-19%
|
(7)
-12%
|
(8)
-9%
|
(9)
-10%
|
(9)
-5%
|
(10)
-6%
|
(10)
-7%
|
(10)
+0%
|
(11)
-2%
|
(11)
-1%
|
(10)
+4%
|
(10)
+3%
|
(9)
+10%
|
(8)
+9%
|
(7)
+7%
|
(7)
+7%
|
(16)
-131%
|
(18)
-9%
|
(19)
-8%
|
(22)
-13%
|
(17)
+23%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(17)
N/A
|
(17)
-3%
|
(17)
-1%
|
(3)
+82%
|
(3)
-6%
|
(4)
-15%
|
(4)
-2%
|
(4)
-3%
|
(4)
-8%
|
(4)
+6%
|
(4)
-14%
|
(5)
-20%
|
(6)
-17%
|
(7)
-13%
|
(8)
-9%
|
(9)
-11%
|
(9)
-6%
|
(10)
-6%
|
(10)
-7%
|
(10)
+1%
|
(11)
-2%
|
(10)
+0%
|
(10)
+5%
|
(9)
+5%
|
(8)
+11%
|
(8)
+10%
|
(7)
+6%
|
(6)
+9%
|
(16)
-141%
|
(17)
-6%
|
(17)
-4%
|
(19)
-12%
|
(14)
+29%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||
| Income from Continuing Operations |
(17)
|
(17)
|
(17)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(10)
|
(10)
|
(9)
|
(8)
|
(8)
|
(7)
|
(6)
|
(16)
|
(17)
|
(17)
|
(19)
|
(14)
|
|
| Net Income (Common) |
(17)
N/A
|
(17)
-3%
|
(17)
-1%
|
(3)
+82%
|
(3)
-6%
|
(4)
-15%
|
(4)
-2%
|
(4)
-3%
|
(4)
-8%
|
(4)
+6%
|
(4)
-14%
|
(5)
-20%
|
(6)
-17%
|
(7)
-13%
|
(8)
-9%
|
(9)
-11%
|
(9)
-6%
|
(10)
-6%
|
(10)
-7%
|
(10)
+1%
|
(11)
-2%
|
(10)
+0%
|
(10)
+5%
|
(9)
+5%
|
(8)
+11%
|
(8)
+10%
|
(7)
+6%
|
(6)
+9%
|
(16)
-141%
|
(17)
-6%
|
(17)
-4%
|
(19)
-12%
|
(14)
+29%
|
|
| EPS (Diluted) |
-1.59
N/A
|
-1.64
-3%
|
-1.66
-1%
|
-0.29
+83%
|
-0.31
-7%
|
-0.36
-16%
|
-0.37
-3%
|
-0.38
-3%
|
-0.41
-8%
|
-0.38
+7%
|
-0.43
-13%
|
-0.48
-12%
|
-0.58
-21%
|
-0.58
N/A
|
-0.61
-5%
|
-0.67
-10%
|
-0.73
-9%
|
-0.77
-5%
|
-0.82
-6%
|
-0.81
+1%
|
-0.83
-2%
|
-0.82
+1%
|
-0.73
+11%
|
-0.67
+8%
|
-3.04
-354%
|
-2.37
+22%
|
-2.03
+14%
|
-1.83
+10%
|
-4.11
-125%
|
-2.37
+42%
|
-2.47
-4%
|
-2.72
-10%
|
-1.85
+32%
|
|
Switch to:
Switch to:
See Also
Discover More
